Adds to growing body of evidence supporting the potential of ITK inhibition as a novel therapeutic for the treatment of a wide range of immune diseases Data will be presented in a poster at ACR ...

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

including 148 and 285 patients with idiopathic pulmonary fibrosis [IPF] and those without IPF. Constipation struck 238 people ...

The UAB Division of Pulmonary, Allergy and Critical Care Medicine is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, ...

The 1-year relative survival rate for all cancers combined fell from 82.3% in the second quarter of 2018 to 77.5% in the second quarter of 2020. The COVID-19 pandemic reduced survival in US cancer ...

The death of a much-loved and popular Devon paramedic who devoted nearly 40 years to helping others has inspired his son to embark on a gruelling challenge in his memory. Stephen Marshall, of Torquay, ...

At the moment there is no cure for pulmonary fibrosis. "When you are diagnosed, they normally give you a three to five-year survival rate. Although dad would get short of breath, he was fine up ...

Scottish salmon has recorded its best survival rate since the pandemic. This was the assessment of Salmon Scotland chief executive Tavish Scott, who says it is thanks to a £1billion investment within ...

“Having a novel combination of well-tolerated medications significantly improving overall survival rates is terrific news for our patients here at Huntsman Cancer Institute and elsewhere.” By ...

The pancreatic cancer survival rate is one of the lowest of common cancers. As a result, pancreatic cancer is one of the most feared diagnoses. Most people diagnosed with pancreatic cancer are no ...

The central bank says further rate hikes possible Inflation is not slowing down Inflationary expectations highest since the start of the year Key rate higher than at the start of the conflict in ...

The Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center will collaborate with GSK to develop stem cell-based models to better understand pulmonary fibrosis and ...